Four linked documents, not one note, carry a composite deckhand's injectable schedule through his prescriber's leave in this MN667 Unit 3 set, the oral overlap end date included. Searches like "mn 667 unit 3 assignment example", "mn667 unit 3 sample" and "mn667 unit 3 example" land here.
Coverage Documentation Set: Long-Acting Aripiprazole for a 33-Year-Old Ferry Deckhand During His Prescriber's Leave
[Student Name]
Purdue University Global
MN667: PMHNP Diagnosis and Management Across the Lifespan III
Unit 3 Assignment
[Instructor Name]
[Date]
Composite patient written as a model document. Doses, dates and lot numbers are bracketed; nothing here is a prescribing instruction.
How to Use This Set
Four documents follow: a progress note, an injection record, a coverage sheet and a consents page. Each is organized around the question a covering colleague is likely to arrive with. Dates are written as dates, not as intervals to be calculated. The prescriber is on leave from Friday [date 1] to Monday [date 2], and both the end of the oral overlap and the second injection fall inside that period.
Document 1: Progress Note
See also: injection record (Document 2), coverage sheet (Document 3).
Composite 33-year-old man with schizophrenia, seen nine days after his first long-acting injection of aripiprazole at [a composite dose], switched from oral aripiprazole because of missed doses on long ferry rotations. He reports the voices are "quieter, more in the background." Mild restlessness in his legs in the evenings; Barnes Akathisia Rating Scale global score 1, questionable (Barnes, 1989). Weight 81 kg, unchanged. Taking oral aripiprazole daily as part of the overlap. No suicidal thoughts. Injection site on the left deltoid healed without redness. Plan: continue the overlap through the date in Document 2; second injection as scheduled; review restlessness at the injection visit.
Document 2: Injection Record
See also: coverage sheet (Document 3) for what to do if any date is missed.
First injection: [date 0], left deltoid, [composite dose]. Lot number: [left for the nurse to record from the vial].
Oral aripiprazole overlap: 14 consecutive days after the first injection, per the product labeling (Otsuka America Pharmaceutical, 2023). Last oral dose: [date 0 + 14 days, written out].
Second injection: due [date 0 + 28 days, written out]. Earliest date allowed: [date 0 + 26 days, written out], since the label advises no sooner than 26 days after the previous injection.
Missed second dose, from the label: if more than four weeks and less than five weeks have passed since the first injection, give the injection as soon as possible; if more than five weeks have passed, restart oral aripiprazole for 14 days with the next injection.
Injection site for the second dose: right deltoid, alternating sites.
Every date the covering colleague may need is written in full, so no one has to count days from an injection date at the end of a long shift.
Document 3: Coverage Sheet
See also: injection record (Document 2) for dates; consents page (Document 4) before calling anyone.
If he misses the due date for the second injection: call him the same day; give the injection as soon as possible within the window in Document 2. If more than five weeks have passed, restart the oral overlap as quoted. Owner: covering clinician, with the clinic nurse.
If restlessness worsens: rate it on the Barnes scale. If the global score reaches 2 or more, or he says he cannot sit still at work, consider a small dose of [a beta-blocker] after checking his blood pressure and heart rate, and tell him the prescriber will review it on her return. Owner: covering clinician.
If the voices return or he stops the oral overlap early: contact his sister, per Document 4, and see him within 48 hours. Owner: covering clinician.
If his rotation moves him to the island terminal: he works one week in four at the island terminal, where there is no clinic. If the second injection falls in that week, give it up to two days early, on or after the earliest date in Document 2, and not on the island. Owner: clinic nurse, who has his rotation schedule.
If he has thoughts of suicide or harming others: assess the same day; emergency department at [named hospital] if needed. Owner: covering clinician.
The one decision not to make alone: a switch to a different antipsychotic or a different long-acting product. It waits for the prescriber's return unless safety demands otherwise, because the switch was chosen after a year of missed oral doses, and changing it would reopen that decision.
Document 4: Consents Page
See also: coverage sheet (Document 3).
His sister: may be contacted about missed appointments, a return of symptoms and emergencies. Signed [date].
The ferry company's occupational health nurse: may be contacted about appointment scheduling only, not his diagnosis or medications. Signed [date].
His pharmacy: may be contacted about his oral aripiprazole supply and the injection supply. Signed [date].
No one else. His parents are not to be contacted.
Rationale
The set was built around a single idea: nothing in it assumes the reader has met him, knows the ferry schedule or has read the prescriber's earlier notes. Long-acting aripiprazole reduces relapse compared with placebo in maintenance treatment (Kane et al., 2012), but its benefit depends on the injections being given on time, and a missed or delayed dose during a colleague's leave is the most likely way the switch could fail.
References
Barnes, T. R. E. (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154(5), 672-676. https://doi.org/10.1192/bjp.154.5.672
Kane, J. M., Sanchez, R., Perry, P. P., Jin, N., Johnson, B. R., Forbes, R. A., McQuade, R. D., Carson, W. H., & Fleischhacker, W. W. (2012). Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: A 52-week, multicenter, randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 73(5), 617-624. https://doi.org/10.4088/JCP.11m07530
Otsuka America Pharmaceutical. (2023). Abilify Maintena (aripiprazole) for extended-release injectable suspension: Prescribing information. Otsuka America Pharmaceutical.
How this MN667 Unit 3 example is structured
Questions, not headings, organize the set, because a covering clinician arrives with a question and needs the document that answers it. The progress note is the shortest part; it records what happened and points elsewhere for what comes next. The injection record is the backbone: dates are written as dates, not as intervals to be calculated, and the missed-dose rule quotes [the product label's window] rather than paraphrasing it. The coverage sheet uses if-then lines, each naming who acts and at what threshold, and ends with the one decision the covering colleague should not make alone, a switch of agent, which waits for the prescriber's return unless safety demands otherwise. Consent is recorded per recipient and per purpose. Nothing in any document assumes the reader has met him or knows the ferry schedule.
Get an MN667 Unit 3 example written to your instructions
Documentation sets in MN667 differ in which pieces they require, so list the documents your Unit 3 prompt names, then include the case and rubric. Within 24-48h, and free the first time, the set arrives cross-referenced, dated rather than counted, and ready for the questions a covering colleague would bring. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
MN667 Unit 3 questions, answered
How is a documentation set different from a long progress note?
A set splits the record by purpose: what happened, what is scheduled, what to do if something changes, and who is allowed to hear it. Each piece answers a different question quickly. A long note may hold the same facts, but a covering clinician has to read all of it to find one date, which is the failure a set is designed to prevent.
Should the set include the product label's missed-dose rules?
Quote them or cite them precisely, and keep any figures bracketed within the composite. Missed-dose windows for long-acting injectables differ by product and by how many doses have been given, so paraphrasing from memory is risky. Name the source, state the rule as it applies to this patient and say who decides when the rule does not fit.
What decisions should a coverage sheet leave to the original prescriber?
Usually the ones that change the plan's direction, such as switching agents or stopping treatment, unless safety cannot wait. Say so on the sheet, with the reason and the exception. A coverage sheet that tries to anticipate every decision becomes unreadable, while one naming the few reserved decisions tells a colleague exactly where their authority ends.